Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Update on Parkinson disease.

    Siderowf A, Stern M.

    Ann Intern Med. 2003 Apr 15;138(8):651-8. Review.PMID: 12693888 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    An update on the treatment of Parkinson's disease.

    Jankovic J.

    Mt Sinai J Med. 2006 Jul;73(4):682-9. Review.PMID: 16878274 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa.

    Marek K, Jennings D, Seibyl J.

    Neurology. 2003 Sep 23;61(6 Suppl 3):S43-8. Review. No abstract available. PMID: 14504379 [PubMed - indexed for MEDLINE]Related articles

    4.
    5.

    Dopamine agonists in early therapy for Parkinson disease: promise and problems.

    Tanner CM.

    JAMA. 2000 Oct 18;284(15):1971-3. No abstract available. PMID: 11035895 [PubMed - indexed for MEDLINE]Related articles

    6.

    The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?

    Mercuri NB, Bernardi G.

    Trends Pharmacol Sci. 2005 Jul;26(7):341-4. Review.PMID: 15936832 [PubMed - indexed for MEDLINE]Related articles

    7.

    Parkinson disease: managing a complex, progressive disease at all stages.

    Giroux ML.

    Cleve Clin J Med. 2007 May;74(5):313-4, 317-8, 320-2 passim. Review.PMID: 17506237 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [The role of dopaminagonists in the treatment of Parkinson's disease]

    Ransmayr G.

    Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. German. PMID: 16277084 [PubMed - indexed for MEDLINE]Related articles

    9.

    Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years.

    Russmann H, Ghika J, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ.

    Neurology. 2004 Nov 23;63(10):1952-4.PMID: 15557522 [PubMed - indexed for MEDLINE]Related articles

    10.

    Managing Parkinson's disease with continuous dopaminergic stimulation.

    Wolters E, Lees AJ, Volkmann J, van Laar T, Hovestadt A.

    CNS Spectr. 2008 Apr;13(4 Suppl 7):1-14; quiz 15-6.PMID: 18408654 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of functional age on the use of dopamine agonists in patients with Parkinson disease.

    Silver D.

    Neurologist. 2006 Jul;12(4):214-23. Review.PMID: 16832240 [PubMed - indexed for MEDLINE]Related articles

    12.

    Current pharmacotherapeutic treatment options in Parkinson's disease.

    Rezak M.

    Dis Mon. 2007 Apr;53(4):214-22. Review.PMID: 17586328 [PubMed - indexed for MEDLINE]Related articles

    13.

    Neuroprotective mechanisms of antiparkinsonian dopamine D2-receptor subfamily agonists.

    Kitamura Y, Taniguchi T, Shimohama S, Akaike A, Nomura Y.

    Neurochem Res. 2003 Jul;28(7):1035-40.PMID: 12737528 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes]

    Szczudlik A, Rudzińska M.

    Neurol Neurochir Pol. 2007 Mar-Apr;41(2 Suppl 1):S6-9. Review. Polish. PMID: 17941452 [PubMed - indexed for MEDLINE]Related articles

    15.

    Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associations.

    Chouza C, Buzó R, Scaramelli A, Romero S, de Medina O, Aljanati R, Dieguez E, Lisanti N, Gomensoro J.

    J Neural Transm Suppl. 2006;(70):427-31. Review. No abstract available. PMID: 17017563 [PubMed - indexed for MEDLINE]Related articles

    16.

    Agonists versus levodopa in PD: the thrilla of whitha.

    Montgomery EB Jr.

    Neurology. 2003 Nov 25;61(10):1462; author reply 1462-3. No abstract available. PMID: 14638991 [PubMed - indexed for MEDLINE]Related articles

    17.

    Parkinson's goal: ease symptoms, slow progression.

    [No authors listed]

    Johns Hopkins Med Lett Health After 50. 2006 Jun;18(4):4-5. No abstract available. PMID: 16795901 [PubMed - indexed for MEDLINE]Related articles

    18.

    The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.

    MacMahon DG.

    Age Ageing. 2003 May;32(3):244-5. No abstract available. PMID: 12720606 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Parkinson's disease.

    Clarke C, Moore AP.

    Clin Evid. 2003 Dec;(10):1582-98. Review. No abstract available. Update in: Clin Evid. 2004 Jun;(11):1736-54. PMID: 15555162 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Parkinson disease therapy: how great is the progress? Possibilities, limitations and future prospects?]

    Schulz-Hanke I.

    Dtsch Med Wochenschr. 2003 Dec 19;128(51-52):2689-90. German. No abstract available. PMID: 14725284 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data